Therapeutic Cancer Vaccines Targeting Molecules Associated with Tumor Angiogenesis
Induction of an endogenous antibody response by therapeutic vaccination could provide an alternative to cost-intensive monoclonal antibody-based treatments for cancer. Since the target of a cancer vaccine will most likely be a self-antigen, self-tolerance of the immune system must be circumvented. U...
Main Author: | Femel, Julia |
---|---|
Format: | Doctoral Thesis |
Language: | English |
Published: |
Uppsala universitet, Institutionen för medicinsk biokemi och mikrobiologi
2014
|
Subjects: | |
Online Access: | http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-229572 http://nbn-resolving.de/urn:isbn:978-91-554-8998-4 |
Similar Items
-
Targeting Tumor Vascular CD99 Inhibits Tumor Growth
by: Elisabeth J. M. Huijbers, et al.
Published: (2019-04-01) -
Development of a Cancer Vaccine Targeting Tumor Blood Vessels
by: Huijbers, Elisabeth J. M
Published: (2012) -
Engineering a Vascularized Hypoxic Tumor Model for Therapeutic Assessment
by: Yuta Ando, et al.
Published: (2021-08-01) -
Soy and Breast Cancer: Focus on Angiogenesis
by: Lenka Varinska, et al.
Published: (2015-05-01) -
Immune Suppression in Tumors as a Surmountable Obstacle to Clinical Efficacy of Cancer Vaccines
by: Danièle Godelaine, et al.
Published: (2011-07-01)